Jefferies Provides a blunt assessment that expresses united ebitda 3% under their estimates, with parts of O2C and 4% below. The global broker remained in the purchase rating at a target price of Rs 1,726 but emphasized that electronics sales are simply due to access to electronics and space access to early access to electronics.
EMKay is more directly about the disappointment, found that the RIL saw 5% and 7% united ebitda and changed profits of Q1fy26 in Rs 181 billion. This underperformance is dedicated to 6% and 5% lower than expected O2C and Zetail EBITDA performance.
Read again | Is Ril’s strong growth durable long-lasting increase in capital spending?
The combined approval of major brokers, in spite of headline-grabling headline profits, the performance of surgery that is not expected to critical business businesses.
Trust in sales, once it is considered a growth machine, promotes failures concerned with the analysts. The motilal oswal noticed that the reliane surgery Ebitda came nearly 7% under their estimated progress in the development of 11% year of comparison to their forecast at about 16%.
Jpmorgan is more concerned about retail Moberia, which declares that retail growth is designed by 11% year-year while the estimates disappeared. The bank investor has been maintained overweight rating but rotated the target price of Rs 1,695 from Rs 1,568, which suggests careful hope despite current headwinds.
The weakness of the retail is dedicated to seasonal pastors and slowly selling electronically, with jeffery explained that the electronics performance was slowed down due to planned progress.
Oil-to-chemical (O2C) business, Ril’s traditional cash cash also experienced analysts with weak performance. Motilal Oswal reported that united O2C EBITDA has reduced 4% quarter-on-quarter, which represents fuel cracks and cracks in the cracks and broken volumes.
Nuvama provides an additional context that explains that the O2C performance is primarily in turnar activities while O2C has been affected by the dispute for future times.
Despite the almost challenges, analysts remain positive about the prospects of the part, whose refines of margins supported in Europe and North America, even when the petrochemical repairs will heal.
Read again | Trust industries share the results of Q1. Should you buy, sell or hold?
Jio shines between wide weakness
The bright spot in a cone mixed quarter is Jio’s confidence, which keeps the firm performance. Motilal Oswal emphasized that RJOO EBITDA rose about 5% quarter-on-quarter, which represents 2% attacks on experierial costs and high extra operation costs of 97%.
Emkay added that the Jio Subscriber added better than the 9.9 million new customers expected, while the average income per user (ARPU) grows 1% of Rs 208.8. The firm performance of Telecom Arm ARG driven by continuing subscriber development and improved the margins of surgery.
Macquarie gives a part wisely checked to be in business level, Jio shows stability while retail shows no signs of healing in challenging times.
In spite of mixed quarterly results, handling ril paints an optimistic picture for future growth prospects. Conglomerate expresses confidence in doubling the EBITDA across groups of 2029, with guidance of growth in the growth of the growth of duplications within 3-4 years, providing management.
Analysts remain powerful with new RIL energy initiatives despite the current challenges of operation. Nuvama describes the new part of energy as the “largest multipladal growth driver” and expected the new energy ecosystem to rampage within 4-6 quarters. Brokerage estimates that a perfectly integrated 10GW polysilicon-to-module facility by closing-FY26 can increase tax after taxes after taxes after taxes after taxes after taxes after taxes after taxes after tax sa buhis pagkahuman sa buhis pagkahuman sa buhis pagkahuman sa buhis pagkahuman sa buhis pagkahuman sa buhis pagkahuman sa buhis pagkahuman sa buhis pagkahuman sa buhis pagkahuman sa buhis pagkahuman sa buhis pagkahuman sa buhis pagkahuman sa buhis pagkahuman sa buhis pagkahuman buhis.
Emkay provides specific timelines indicating that new energy ecosystems can be fully operated within 4-6 quarters by a strategic collaboration for several years, with potential for immediate growth.
Prabhudas Lilladher has upgraded the stock from holding the rating, introducing an appreciation of Rs 111 per share for new energy part, which shows the growing business of upright.
Despite the disappointing quarterly performance, most of the main brokerapes keep positive ratings of Parts of the ril. Jefferies maintained a shopping rating with a target price of Rs 1,726, Morgan Stanley went on a target price of Rs 1,617, and Emkay has gained a target price of Rs 1,600.
Nuvama continues a purchase rating at a target price of Rs 1,767, the motilal Oswal continues at a target price of Rs 1,695. HSBC And Nomura both continues to buy ratings with targeted price of Rs 1,630 and Rs 1,600.
However Macquarie gives a note that states that they believe that trust price can see this rival of the results of an Rs 1,500 price target.
